SMC-346
GABAA Receptor Alpha 1 Antibody, Clone N95/35
Cannot supply to this region.
- SKU:
- SMC-346
- Additional Names:
- ECA4, EJM, EJM5, GABA receptor alpha 1 polypeptide, GABA(A) receptor, GABA(A) receptor subunit alpha 1, GABA(A) receptor subunit alpha-1, GABA(A) receptor, alpha 1, GABRA 1, GABRA1, Gamma aminobutyric acid (GABA) A receptor alpha 1, Gamma aminobutyric acid A receptor alpha 1, Gamma aminobutyric acid receptor subunit alpha 1, Gamma-aminobutyric acid receptor subunit alpha-1, GBRA1_HUMAN
- Application:
- IHC, WB, IF, ICC, Microarray
- Concentration:
- 1 mg/ml
- Species Reactivity:
- Human
- Purification:
- Protein G Purified
- Storage Conditions:
- -20[o]C
- Supplier:
- StressMarq Biosciences
- Host:
- Mouse
- Reactivities:
- Human, Mouse, Rat
- Buffer:
- PBS, 50% glycerol, 0.1% azide
- Immunogen:
- Fusion protein amino acids 355-394 of human GABA-A-R-Alpha1
- Clone:
- N95/35 (Formerly sold as S95-35)
- Uniprot:
- P14867
- Synonyms:
- DEE19;ECA4;EIEE19;EJM;EJM5;GABA(A) receptor subunit alpha-1;GABA(A) receptor, alpha 1;GABAA alpha 1;GABAA-alpha1;GABAAR alpha1;GABAAR-alpha1;Gabr;Gabra-1;gamma-aminobutyric acid (GABA) A receptor, alpha 1;gamma-aminobutyric acid receptor subunit alpha-1;gamma-aminobutyric acid type A receptor alpha1 subunit
- Extra Details:
- The GABA A receptor alpha 1 subunit (GABRA1) is a critical component of the GABA A receptor complex, a family of fast-acting ligand-gated ion channels that mediate the majority of rapid inhibitory neurotransmission in the central nervous system. These receptors are pentameric structures composed of various subunits, with the alpha 1 subunit being the most abundantly expressed in the adult brain. GABRA1 plays a central role in maintaining synaptic inhibition, regulating neuronal excitability, and shaping network oscillations essential for cognitive and behavioral functions. Emerging evidence links GABRA1 dysfunction to the pathophysiology of several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Altered expression or function of the alpha 1 subunit has been associated with key features of neurodegeneration, such as disrupted inhibitory signaling, synaptic imbalance, and increased neuronal vulnerability. As such, GABRA1 is gaining attention as a potential biomarker and therapeutic target in the early detection and treatment of these disorders. Advancements in molecular imaging, transcriptomics, and electrophysiology are enhancing our understanding of GABRA1's spatial distribution and functional dynamics in both healthy and diseased brains. These insights are crucial for developing targeted interventions aimed at restoring inhibitory tone and preserving neural circuitry in neurodegenerative conditions.
- Shipping Conditions:
- Blue Ice